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~ Cardiac Risk Assessment Following Vascular 
Surgery-- Independent Validation of a Bayesian 
Prediction Model 
Gilbert J. Ultalien, Sumita D. Paul, Robert C. Hendal, Mylan C. Cohen, Lee 
A. Reisher, Kenneth A. Brown, Stuart W, Zarich, Jeffrey A. LSPpo, Kim 
A. Eagle. Massachusetts Hospital Boston, MA, Univ. of Massachusetts, 
Worcester, MA; Deaconess Hospital, Boston, MA; Univ. of Vermont, 
Burlington VT~; Johns Hopkins Univ., Baltimore, MD; Yale Univ., New Haven 
Ct. Northwestern Univ, Chicago, ILL; Unfv. of Michigan, Ann Arbor, MI 
We previously described a Bayesian cardiac risk prediction model developed 
from a "training" set of 567 vascular surgery pts from 2 medical centers (43rd 
ACC). Here, we report he results of a validation based on 514 additional pts 
from 3 centers. The original model permitted sequential estimation of dsk of 
fatal/non-fatal MI based on surgery type (TYPE), TYPE + clinical markers 
(CLIN): (HxMI, Angina, CHF, Diabetes, age > 70 y, pdor CABG), and TYPE 
+ CLIN + dlpyridamole thallium data (fixed/reversible defects, ischemic ST 
changes). Model performance was assessed using receiver operator curves 
(ROC) and by comparing observed event rates to risk estimates. 
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Results are shown above for both the training and validation sets (1,081 
patients). Figure I: ROC areas were 81 -I- 3% for the training set and 74 
± 9%, 72:1: 7%, and 76 -~ 5% for each of the 3 validation setS (p = NS). 
Figure 2: Observed and estimated sks were comparable for the training 
set ("goodness of fit" p = 0.75), and all 3 validation sets (p = 0.55, 0.10, 
0.45, respectively). Conclusions:The Bayesian prediction model can reliably 
estimate the risk of a pedoperative cardiac event in beth the training and 
validation setS and is thus generalizable to the vascular surgery population. 
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["~"0--~ Evaluation of Selntigraphy Ventilction/Perfusion 
Using Tc-99m Diethylenetriamine Pantaceti¢ Acid 
(OTIPA) Aerosol in the Diagnosis of Pulmonary 
Embol ism 
Nelson P. Trujillo, Jonathan P. Pratt, Sachin Talusani, Robert A. Qualfo, 
O~vid Kumpe, James L. Lear. University of Colorado Health Sciences 
Center, Denver. CO 
Ventilation/pedusion (V/Q) scintigraphy has generally been performed using 
Xenon-133 for ventilation. However, PIOPED and other studies that have em- 
ployed this technique have raised questions about accuracy in the diagnosis 
of pulmonary embolism (PC-). 
We evaluated the accuracy of V/Q scintigraphy using Tc-ggm DTPA 
aerosol, as opposed to Xenon-133, in the evaluation of suspected PE. The 
use of Tc-99m DTPA oilers potential advantages: greater esolution and the 
ability to perform ventilefidn imaging in the same eight views as those of the 
perfusion study. 
Diagnostic riteria developed specifically for Tc-99m DTPA aerosol were 
prospectively applied to 2922 patients being evaluated for suspected PE 
over a six year period. Of these patients, 16% had normal V/Q scans, 
56% had low probability scans, 10% had indeterminate scans, 9% had 
medium probability scans, and 9°/= had high probability scans. The total 
percent of scans in normal, high, or low categories was 81%, compared to 
61% in PIOPED. Pulmonary angiography was performed on 264 patients. 
Pulmonary emholic disease was identified in 0/1 ((T/O) of normal scans, 3/59 
(5%) of low probability scans, 13/54 (24%) of Indeterminate scans, 35/94 
(43%) of medium probability scans, and 53/56 (95%) of high probability 
scans. Estimated incidence of PE in the total population was 15%. 
These results indicate that V/Q scintigraphy using Tc-99m DTPA aerosol 1) 
is useful in the diagnosis of pulmonary emholic disease and 2) has accuracy 
which is superior to published results using Xenon-133, including PIOPED. 
We believe that Tc-99m DTPA aerosol should replace Xenon-133 in V/L~ 
scintigraphy for the diagnosis of suspected pulmonary embolism, 
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~0"~ AnticoagulaUon Monitoring: Accurate Results W'dh 
Patient Self-Tssting in a Multieentar Trial 
Richard Becker, Daniel Becker, Maureen Andrew, Jack Ansell, 
Douglas Tdplett, Catherine Cimini, Frank LaDuca, and the Oral 
Anticoagulation Study Investigators. Thrombosis Research Center, 
University of Massachusetts Medical Center, Worcester, MA 
A novel whole blood Prothrombin "rime (PT) system (ProTIME Micrecoagu. 
lation System, International Technidyne Co., Edison, NJ), was tested in five 
anticoagulation clinics to assess the patient's ~,b!tity to collect and test a 
finger.stick blond sample (FS) and to assess the accuracy of the ProTIME 
result (INR) with the lab plasma assay. FS and venous samples (VS) were 
obtained from control volunteers (n = 65) and patients receiving warfarin 
(n = 230). Written, video, and verbal instruction was provided by a Health 
Care Professional (HCP). Once collected, blood was automatically tested in 
triplicate with concurrent control tests. VS was sent to the hospital lab for 
testing (ISI ranging 1.2 to 2.1). A sample of the plasma was shipped to a 
reference lab where the assay was repeated (Recemboplastin, ISI = 1.0). 
The HCP noted patient attempts necessary to obtain a ProTIME result. The 
first attempt was successful for 83% of the patients. An additional 10% were 
successful in the second trY. Most graded the monitor "Easy" to use (65%) 
while few identified it"Difficult" (7.5%). Participants preferred the FS sampling 
method (92%). No difference was detected between ProTIME results of VS 
and FS (Student's t Test). The ProTIME INR was significantly correlated to 
the reference lab (r = 0.94 for VS and r = 0.93 for FS). The correlation of FS 
to each hospital site ranged from r = 0.89 to r = 0.93. Conclusion: Patients 
prefer and can readily test themselves with the ProTIME Monitor yielding test 
results that are highly correlated to the laboretory. 
Coronary Artery Core: Effects to Improve 
Efficiency 
Wednesday, March 27, 1996, 2:00 p.m.-3:30 p.m. 
Orange County Convention Center, Room 224C 
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J ' ~  The Effect of Public Release of Bypass Surgery  
Mortality Data on Procedural Access in the Elderly: 
New York State 
Eric D. Peterson, James G. Jollis, Elizabeth R. DeLong, S. Robert Collins, 
Lawrence H. Muhlbaler, Daniel B. Mark. Duke University Medical Center, 
Durham, NC 
New York (NY) State has released provider-level bypass surgery (CABG) 
mortal~ data since 1989. Some spaculate that this policy may force higher- 
dsk patients, particularly the elderly, to go out.of-state for CABG or to forgo 
intervention. Using Medicare data, we examined CABG use in and outside 
NY. We tested (1) whether the % of patients aged _> 65 years who received 
CABG outside NY increased from 1987 to 1992 and (2) whether CABG use 
declined in NY in higher-risk patients, defined as those aged >_ 70 years with 
acute MI (AMI), versus US practice patterns dudng this pedod. 
1967 1988 1989 1990 1991 1992 
NY Medicare CABG 
re~pients, n 5488 5784 6148 7093 8279 9075 
Out-of-State CABG, % 13.2 15.0 14.8 13.1 13.3 11.6 
NY PIs aged_> 70 yr 
with AMI + CABG, % 4.4 5.8 6.3 8.8 7.7 8.1 
US Pts age > 70 yr with 
AMI + CABG, % 6.9 8.4 9.2 10.5 10A 11.1 
The % of NY's elderly migrating out-of-state for CABG has declined since 
the release of provider profiling data. In addition, an increasing % of NY's 
high-risk elderly patients with AMI received CABG over this period in parallel 
with national practice panems. 
Conclusion: Public release of provider-level CABG mortality data in NY 
does not appear to have limited access to CABG procedures for the eldedy. 
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[~]  Potentiel for Cost in Cost Coronary Savings High 
Bypass Surgery Patients: A New York State Analysis 
Patdcia A. Cowper, Elizabeth R. DeLong, Edc 3. Feterson, Edward 
L. Hannan, Kevin T. Ray, Michael Racz, James G. Joitis. Daniel B. Mark, 
Duke University Medical Center, Durham, NC 
To assess potential for cost savings, we examined the extent and sources 
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of variation in resource use for coronary artery bypass surgery (CABG) in 
20 New York (NY) hospitals in 1992 (n = 10,080), Patient (pt) level costs, 
exclusive of professional fees, ware calculated using hospital-spacific, de- 
partment cost to charge ratios and were leveled for hospital-specific factors 
(e.g. teaching costs, input casts). Preoperative risk factors were obtained 
from the NY Cardiac Surgery Reporting System. Mean cost and LOS (4- SD) 
were $14,448:1:$8,606 and 13.5 :t: 8.6 days. Pt factors explained 27% of 
variation in cast and 30% in LOS, with 1" resource use associated with 1" 
age, female gender, ,I. ejection fraction, CHF, prior heart surgery and stroke. 
Hieramhtcai modeling revealed that individual hospitals explained 63% of 
r_~idcal variation In cos'., after adjusting for pt factors. The range of predicted 
cost among hospitals for a typical pt (65 year old white male; 3 diseased 
vessels: ejection fraction 50-59%) was $9,000.-$23,000 (see figure). 
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Conclusions: After adjusting for lot risk factors and differences in input 
costs, considerable variation in CABG costs remained among NY hospitals. 
This inter-hospifal variation identities the potential for substantial cost savings 
in some hospitals. 
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~"~ Validation of a Cllnlcel Prediction Rule for Predicting 
Left Ventricular Funct ion  Pos t  Acute Myocardial  
Infarction in a Communi ty  Hospital Setting 
Ken "robin, Robert Stumol, Daniel Harber, Dean Karavite, Kim Eagle. 
Botstord General Hospital, Farmington Hills, MI; University of Michigan 
Medical Center, Ann Arbor, MI 
Previously, we (KE) reported that if a post myocardial infercti0n patient 
meets four simple clinical and/or ECG criteria, their left ventricular ejection 
fraction (LVEF) is >_ 40% with a positive predictive value of 0.98. These 
criteria were (1) no history of congestive heart failure (CHF), (2) an ECG 
without oither a LBBB, paced rhythm, or left ventdcular hypertrophy (LVH) 
with strain, (3) an index MI that is not an anterior Q-wave, and (4) no 
history of a prior Q-wave MI outside the currant ischemic zone. In order to 
validate this in the community hospital setting, we identified 213 patients 
admitted with the primary discharge diagnosis of acute myocardial infarction 
(AMI) (ICD Code 410.01--410.91 ) between 6/23/93-3/7/95. All patients in the 
study met standard clinical and enzymatic definitions for acute infarction and 
had undergone at least one measure of LVEF such as echocardiography, 
ventricular angiography or gated blood pool scan. Of 213 patients, the clinical 
rule predicted that 83 (39%) would have LVEF > 40%. Of these 83 patients, 
71 had an ejection fraction > to 40=/=, for a positive predictive value of 86%. Of 
the 12 patients that were incorrectly predicted to have preserved LV function, 
67% (6/12) had an index non-Q anterior MI with an average CK peak of 1300 
U/L. 
Conclusion: This simple clinical prediction rule has a positive predictive 
value of 86% when applied in the community hospital setting. It appears that 
patients with extensive anterior non Q-wave MI may be one group where the 
rule is Inaccurate, We believe that when a technology-based assessment of 
left ventdcular function is considered in the post-MI patient, this prediction 
rule may allnw a more cost effective selection of patients for whom the test 
will be es!'edally helpful and that as many as 40% of patients may require 
no tastL~g at all. 
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[801-~-J-4 Predictors of Increased Length of Stay of Patients 
Undergoing Coronary Intervention Procedures 
Lad Harmll, Robert Piana, Alexander Pedan, Andrew Selwyn, Thomas Lee, 
Igor F. Paiacios. Cardiac Unit, Massachusetts General Hospital, Brigham 
and Women's Hospital (Partners Inc), Harvard Medical School, Boston 
In the present era of health care reform there is a need to decrease cost in 
patients undergoing coronary intervention procedures. Since post-procedure 
length of stay (LOS) is an important determinant of cost, the present study 
was undertaken to determine factors responsible for increased LOS. A total 
of 1646 patients undenvent 1792 coronary interventionai procedures to treat 
2353 lesions at the Massachusetts General Hospital and the Brigham and 
Women's Hospital from 111/94 to 12/31/94. There were 1139 males and 507 
females, mean age 64 ± 12 years. Median LOS was 4 4- 5 days. Demo- 
graphic, comorbid, procedural and post-procedure adverse event variables 
were included in a stepwise multiple linear regression analysis. Independent 
predictors of LOS Include blood transfusion (p = 0.001), elective by-pass 
surgery (CABG) (p = 0.001 ), vascular repair (p = 0.001), hospital acute renal 
failure (p = 0,001), total number of procedures (p = 0.001 ), history of myocar- 
dial Infarction (p = 0.001), ACC/AHA type C lesion intervention (p = 0,001), 
stent utilization (p = 0.001), diabetes mellltus (p = 0.001), emergent CABG (p 
= 0.001 ), evolving myocardial infarction (p = 0.001 ), cerabrovescular disease 
(p = 0.01) and congestive heart failure (p = 0.0t). The R value of the model 
was 0,6. Conclusion: This model demonstrates the complexity of patients 
undergoing coronary interventions and the factors surrounding their process 
of care. Intervention on select predictors offers the opportunity to model LOS, 
decrease cost and improve quality of care. 
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~ '~ ' l  The Impact of Stress Testing on Subsequent 
Invasive Cardiac Procedures 
David E. Wannberg, Mide A. Kellett, John D. Dickens, David J. Malanka, 
Leonard M. Keitson, Robert B. Keller. Maine Medical Center, Portland ME; 
Maine Medical Assessment Foundation, Augusta, ME 
There has been considerable interest in explaining the variable use of in- 
vasive cardiac procedures, however, the role of stress testing has been 
relatively ignored. Because most patients being evaluated for chest pain 
initially undergo a stress test, we hypothesized that geographic variation 
in Invasive procedures would largely be explained by the vadable use of 
stress testing. Methods: Twelve coronary anglography service areas were 
constructed for Medicare beneficiaries in Northern New England. Age/sex 
adjusted utilization rates were developed for three procedure categories: 
total stress test, coronary angiography and revascutadzation. Total stress 
tests were further stratified into non-imaging and imaging procedures (e.g., 
thallium). Tests done in follow-up to |nvasive procedures were excluded 
(e.g. stress test following revascularizattons). Linear regression was used 
to assess the relationship between procedure categories. Results: A tight 
relationship was found between tctai stress test rates and the rates of sub- 
sequent coronary angiograbhy (R 2 = 0.61, p < 0.005). Most of the variance 
was explained by imaging stress tests (R 2 : 0.50, p < 0.02). A very strong 
relationship was found between coronary angingraphy and revescularization 
(R ~ = 0.82, p < 0.0001 ). Finally, a clear relationship between total stress tests 
and subsequent revescularizstions was also found (R s = 0.55, p < 0.006). 
Conclusiorr.lhe population based rates of diagnostic testing largely explained 
the variance associated with subsequent therapeutic interventions. Our re- 
sults suggest that local testing intensity is an important determinant of the 
vadable use of invasive cardiac procedures. 
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1"~'~ Cost ve Outcome for Redo Coronary Surgery vs 
Coronary Angioplasty for Clinical Recurrence After 
Coronary Surgery 
William S. Wstntraub, Patrick D. Mauldin, Edmund Becket, Ellis I -  Jones, 
Douglas C, Morris, Spencer B. King lit, Robert A. Guyton, Joseph 
M. Craver. Emory U School of Medicine, Atlanta GA 
Coronary revasculadzstion after prior corenary surgew was studied in 4174 
patients: PTCA in 2613 and redo CABQ in 1561. PTCA patients were more 
often female (20% vs 16%, p = 0,002), fewer had prior myocardial Infamtion 
(MI) (56% vs 62%, p = 0,0003) or congestive failure (9% vs 15%, p < 0.0001 ). 
Patients were similar in age (61 ± 10), hypertension (48%), diabetes (22%) 
PTCA Redo CABG P Value 
tn Hospits! 
Mortality ~.2Yo 6.8% <0.0001 
Stroke 0% 2.8% 0,27 
Myocardial Infarction 1,5% 5.4% <0.0001 
Length of Stay (days) 3 ± 4 11 :E 12 <0.0001 
Cost (1000's) $8.5 ~ 7.3 $2.4.2 ± 17,3 <0.0001 
5 Years 
SuNival 80% 76% <0,0001 
Corrected Survival 81% 78% NS 
MI Freedom 79% 80% <0.08 
CABG Freedom 96=/. 74% <0.0001 
PTCA Freeclom 90% 58% <0.0001 
Recurrent Angina 48% 41% 0,0002 
